Swiss National Bank Supernus Pharmaceuticals, Inc. Transaction History

Swiss National Bank

$137 Billion
Q1 2025

A detailed history of Swiss National Bank transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Swiss National Bank holds 107,000 shares of SUPN stock, worth $3.49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

107,000

Previous 108,400 1.29%

Holding current value

$3.49 Million

Previous $3.92 Million 10.59%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$31.17 - $40.0 $43,638 - $56,000	-1,400 Reduced 1.29%	107,000 $3.5 Million
Q4 2024 Feb 10, 2025	BUY	$31.89 - $37.83 $25,512 - $30,264	800 Added 0.74%	108,400 $3.92 Million
Q4 2023 Feb 06, 2024	SELL	$22.72 - $29.68 $274,912 - $359,128	-12,100 Reduced 10.11%	107,600 $3.11 Million
Q3 2023 Nov 08, 2023	BUY	$27.57 - $32.91 $35,841 - $42,782	1,300 Added 1.1%	119,700 $3.3 Million
Q2 2023 Aug 09, 2023	BUY	$29.91 - $38.73 $53,838 - $69,714	1,800 Added 1.54%	118,400 $3.56 Million
Q1 2023 May 10, 2023	SELL	$34.93 - $42.03 $440,118 - $529,578	-12,600 Reduced 9.75%	116,600 $4.22 Million
Q4 2022 Feb 08, 2023	BUY	$31.09 - $37.88 $77,725 - $94,700	2,500 Added 1.97%	129,200 $4.61 Million
Q3 2022 Nov 09, 2022	BUY	$28.79 - $35.41 $28,790 - $35,410	1,000 Added 0.8%	126,700 $4.29 Million
Q1 2022 May 09, 2022	BUY	$28.51 - $32.9 $245,186 - $282,940	8,600 Added 7.34%	125,700 $4.06 Million
Q3 2021 Nov 08, 2021	BUY	$23.54 - $31.39 $23,540 - $31,390	1,000 Added 0.86%	117,100 $3.12 Million
Q2 2021 Aug 06, 2021	SELL	$26.72 - $33.19 $114,896 - $142,717	-4,300 Reduced 3.57%	116,100 $3.58 Million
Q1 2021 May 07, 2021	BUY	$24.15 - $31.45 $31,394 - $40,885	1,300 Added 1.09%	120,400 $3.15 Million
Q3 2020 Nov 09, 2020	BUY	$20.2 - $25.05 $40,400 - $50,100	2,000 Added 1.71%	119,100 $2.48 Million
Q2 2020 Aug 05, 2020	BUY	$17.09 - $24.89 $263,186 - $383,306	15,400 Added 15.14%	117,100 $2.78 Million
Q1 2020 May 08, 2020	BUY	$14.45 - $24.69 $18,785 - $32,097	1,300 Added 1.29%	101,700 $1.83 Million
Q4 2019 Feb 06, 2020	BUY	$19.93 - $29.13 $39,860 - $58,260	2,000 Added 2.03%	100,400 $2.38 Million
Q3 2019 Nov 12, 2019	BUY	$25.47 - $33.37 $28,017 - $36,707	1,100 Added 1.13%	98,400 $2.7 Million
Q2 2019 Aug 02, 2019	BUY	$29.96 - $38.87 $62,916 - $81,627	2,100 Added 2.21%	97,300 $3.22 Million
Q1 2019 May 10, 2019	BUY	$32.77 - $41.99 $95,033 - $121,771	2,900 Added 3.14%	95,200 $3.34 Million
Q4 2018 Feb 13, 2019	BUY	$30.84 - $49.51 $64,764 - $103,971	2,100 Added 2.33%	92,300 $3.07 Million
Q2 2018 Aug 09, 2018	BUY	$44.1 - $59.85 $79,380 - $107,730	1,800 Added 2.04%	90,200 $5.4 Million
Q1 2018 May 04, 2018	BUY	$37.15 - $46.9 $74,300 - $93,800	2,000 Added 2.31%	88,400 $4.05 Million
Q4 2017 Feb 07, 2018	BUY	$36.4 - $42.6 $105,560 - $123,540	2,900 Added 3.47%	86,400 $3.44 Million
Q3 2017 Nov 03, 2017	BUY	$36.75 - $49.65 $3.07 Million - $4.15 Million	83,500	83,500 $3.34 Million

Others Institutions Holding SUPN

# of Institutions

305

Shares Held

60.8M

Call Options Held

8.8K

Put Options Held

6.3K

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.75B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Supernus Pharmaceuticals, Inc. Transaction History